Tag: anti-IgE
Biologics in Severe Asthma: How Anti-IgE and Anti-IL-5 Therapies Change the Game
Anti-IgE and anti-IL-5 biologics are transforming severe asthma care by targeting specific immune pathways. Learn how omalizumab, mepolizumab, and benralizumab reduce flare-ups, cut steroid use, and restore quality of life for those who don’t respond to standard treatments.
read morerecent posts
Physicians prescribing generic medications now face rising legal liability as federal rulings shield drug manufacturers from lawsuits. Learn how to protect yourself with proper documentation and prescribing practices.
Published ON: 10 MarBioequivalence testing for combination products like FDCs, inhalers, and topical creams is far more complex than for single-drug generics. Regulatory, technical, and financial hurdles delay affordable access to life-saving medications.
Published ON: 13 MarNasal congestion from overused decongestant sprays is common and reversible. Learn how rebound congestion works, why stopping the spray is the only cure, and what actually helps you recover - backed by clinical evidence.
Published ON: 5 MarSocial media is transforming how patients learn about generic drugs. From TikTok explainers to Instagram Reels, digital platforms are cutting through confusion and building trust-no brochures needed.
Published ON: 17 MarCounterfeit medications are a growing global threat, with millions of fake pills and injections seized each year. Real cases from 2025 reveal how dangerous these fakes are-and what we must do to stop them.
Published ON: 3 Mar